[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Pages 3462-3467]
[FR Doc No: 2019-01962]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1721]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Investigational New
Drug Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by March
14, 2019.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax:<PHONE_NUMBER>, or emailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0014.
Also include the FDA docket number found

in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Investigational New Drug Application--21 CFR Part 312

OMB Control Number 0910-0014-Extension

    This information collection supports FDA regulations in 21 CFR part
312 covering Investigational New Drugs. Part 312 implements provisions
of section 505(i) of the Federal Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 355(i)) requiring FDA to issue regulations under which
the clinical investigation of the safety and effectiveness of
unapproved new drugs and biological products can be conducted.
    FDA is charged with implementing statutory requirements that ensure
drug products marketed in the United States are shown to be safe and
effective, properly manufactured, and properly labeled for their
intended uses. Section 505(a) of the FD&C Act provides that a new drug
may not be introduced or delivered for introduction into interstate
commerce in the United States unless FDA has previously approved a new
drug application (NDA). FDA approves an NDA only if the sponsor of the
application first demonstrates that the drug is safe and effective for
the conditions prescribed, recommended, or suggested in the product's
labeling. Proof must consist, in part, of adequate and well-controlled
studies, including studies in humans, that are conducted by qualified
experts.
    The investigational new drug application (IND) regulations under
part 312 establish reporting requirements that include an initial
application as well as amendments to that application, reports on
significant revisions of clinical investigation plans, and information
on a drug's safety or effectiveness. In addition, the sponsor is
required to give FDA an annual summary of the previous year's clinical
experience. The regulations also include recordkeeping requirements
pertaining to the disposition of drugs, records pertaining to
individual case histories, and certain other documentation verifying
the fulfillment of responsibilities by clinical investigators.
    Submissions are reviewed by medical officers and other Agency
scientific reviewers assigned responsibility for overseeing a specific
study. The details and complexity of these requirements are dictated by
the scientific procedures and human subject safeguards that must be
followed in the clinical tests of investigational new drugs.
    The IND information collection requirements provide the means by
which FDA can monitor the clinical investigation of the safety and
effectiveness of unapproved new drugs and biological products,
including the following: (1) Monitor the safety of ongoing clinical
investigations; (2) determine whether the clinical testing of a drug
should be authorized; (3) ensure production of reliable data on the
metabolism and pharmacological action of the drug in humans; (4) obtain
timely information on adverse reactions to the drug; (5) obtain
information on side effects associated with increasing doses; (6)
obtain information on the drug's effectiveness; (7) ensure the design
of well-controlled, scientifically valid studies; and (8) obtain other
information pertinent to determining whether clinical testing should be
continued and information related to the protection of human subjects.
Without the information provided by industry as required under the IND
regulations, FDA cannot authorize or monitor the clinical
investigations that must be conducted before authorizing the sale and
general use of new drugs. These reports enable FDA to monitor a study's
progress, to ensure the safety of subjects, to ensure that a study will
be conducted ethically, and to increase the likelihood that the sponsor
will conduct studies that will be useful in determining whether the
drug should be marketed and available for use in medical practice.
    To assist respondents with certain reporting requirements under
part 312, we have developed two forms: Form FDA 1571 entitled,
``Investigational New Drug Application (IND)'' and Form FDA 1572
entitled, ``Statement of Investigator.'' Anyone who intends to conduct
a clinical investigation must submit Form FDA 1571 as instructed. The
reporting elements include: (1) A cover sheet containing background
information on the sponsor and investigator; (2) a table of contents;
(3) an introductory statement and general investigational plan; (4) an
investigator's brochure describing the drug substance; (5) a protocol
for each planned study; (6) chemistry, manufacturing, and control
information for each investigation; (7) pharmacology and toxicology
information for each investigation; and (8) previous human experience
with the investigational drug. Form FDA 1572 is executed and submitted
by the IND sponsor before an investigator may participate in an
investigation. It includes background information on the investigator
as well as the investigation, and a general outline of the planned
investigation and study protocol.
    In the Federal Register of October 4, 2018 (83 FR 50102) FDA
published a 60-day notice requesting public comment on the proposed
collection of information. We received one comment. The comment did not
pertain to the regulations or estimates provided in the 60-day notice
requesting that OMB extend its approval for the information collection
in these regulations. Rather, the comment discussed issues that
pertained to Docket No. FDA-2010-D-0503 for the ``Guidance for Clinical
Investigators, Sponsors, and Institutional Review Boards (IRBs):
Investigational New Drug Applications (INDs)--Determining Whether Human
Research Studies Can Be Conducted Without an IND.'' Accordingly, we
have submitted the comment to Docket No. FDA-2010-D-0503.
    FDA estimates the burden of this collection of information as
follows:

                      Table 1--Estimated Annual Reporting Burden for Human Drugs (CDER) \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
         21 CFR section              Number of     responses per   Total annual   Average burden    Total hours
                                    respondents     respondent       responses     per response
----------------------------------------------------------------------------------------------------------------
Sec.   312.2(e); Requests for                400               1             400              24           9,600
 FDA advice on the applicability
 of part 312 to a planned
 clinical investigation.........
Sec.   312.8; Requests to charge              74            1.23              91              48           4,368
 for an investigational drug....
Sec.   312.10; Requests to waive              86            1.84             158              24           3,792
 a requirement in part 312......

Sec.   312.23(a) through (f);              2,187             1.7           3,718           1,600       5,948,800
 IND content and format
 (including Form FDA 1571)......
Sec.   312.30(a) through (e);              4,418            5.52          24,387             284       6,925,908
 Protocol amendments............
Sec.   312.31(b); Information              6,691            3.32          22,214             100       2,221,400
 amendments.....................
Sec.   312.32(c) and (d); IND                867           15.78          13,681              32         437,792
 safety reports.................
Sec.   312.33(a) through (f);              3,376            2.86           9,655             360       3,475,800
 IND annual reports.............
Sec.   312.38(b) and (c);                    930            1.61           1,497              28          41,916
 Notifications of withdrawal of
 an IND.........................
Sec.   312.42; Sponsor requests              198            1.38             273             284          77,532
 that a clinical hold be
 removed, including sponsor
 submission of a complete
 response to the issues
 identified in the clinical hold
 order..........................
Sec.   312.44(c) and (d);                     12            1.16              14              16             224
 Sponsor responses to FDA when
 IND is terminated..............
Sec.   312.45(a) and (b);                    231            1.84             425              12           5,100
 Sponsor requests for or
 responses to an inactive status
 determination of an IND by FDA.
Sec.   312.47; Meetings,                     122            1.51             184             160          29,440
 including ``End-of-Phase 2''
 meetings and ``Pre-NDA''
 meetings.......................
Sec.   312.54(a); Sponsor                     15             2.4              36              48           1,728
 submissions to FDA concerning
 investigations involving an
 exception from informed consent
 under Sec.   50.24.............
Sec.   312.54(b); Sponsor                      2               1               2              48              96
 notifications to FDA and others
 concerning an IRB determination
 that it cannot approve research
 because it does not meet the
 criteria in the exception from
 informed consent in Sec.
 50.24(a).......................
Sec.   312.56(b), (c), and (d);            6,100               7          42,700              80       3,416,000
 Sponsor notifications to FDA
 and others resulting from: (1)
 The sponsor's monitoring of all
 clinical investigations and
 determining that an
 investigator is not in
 compliance with the
 investigation agreements; (2)
 the sponsor's review and
 evaluation of the evidence
 relating to the safety and
 effectiveness of the
 investigational drug; and (3)
 the sponsor's determination
 that the investigational drug
 presents an unreasonable and
 significant risk to subjects...
Sec.   312.58(a); Sponsor's                   73               1              73               8             584
 submissions of clinical
 investigation records to FDA on
 request during FDA inspections.
Sec.   312.70; During the                      4               1               4              40             160
 disqualification process of a
 clinical investigator by FDA,
 the number of investigator
 responses or requests to FDA
 following FDA's notification to
 an investigator of its failure
 to comply with investigation
 requirements...................
Sec.   312.110(b)(4) and (b)(5);              11           26.28             289              75          21,675
 Written certifications and
 written statements submitted to
 FDA relating to the export of
 an investigational drug........
Sec.   312.120(b); Submissions             1,414            8.62          12,189              32         390,048
 to FDA of ``supporting
 information'' related to the
 use of foreign clinical studies
 not conducted under an IND.....
Sec.   312.120(c); Waiver                     35            2.34              82              24           1,968
 requests submitted to FDA
 related to the use of foreign
 clinical studies not conducted
 under an IND...................
Sec.   312.130; Requests for                   3               1               3               8              24
 disclosable information in an
 IND and for investigations
 involving an exception from
 informed consent under Sec.
 50.24..........................
Sec.  Sec.   312.310(b) and                  935            2.77           2,590               8          20,720
 312.305(b); Submissions related
 to expanded access and
 treatment of an individual
 patient........................
Sec.   312.310(d); Submissions               480            2.15           1,032              16          16,512
 related to emergency use of an
 investigational new drug.......
Sec.  Sec.   312.315(c) and                  118            2.52             297             120          35,640
 312.305(b); Submissions related
 to expanded access and
 treatment of an intermediate-
 size patient population........
Sec.   312.320(b); Submissions                10            12.9             129             300          38,700
 related to a treatment IND or
 treatment protocol.............
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............      23,125,527
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

                    Table 2--Estimated Annual Recordkeeping Burden for Human Drugs (CDER) \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
         21 CFR section              Number of      records per    Total annual         per         Total hours
                                   recordkeepers   recordkeeper       records      recordkeeping
----------------------------------------------------------------------------------------------------------------
Sec.   312.52(a); Sponsor                  1,300               1           1,300               2           2,600
 records for the transfer of
 obligations to a contract
 research organization..........
Sec.   312.57; Sponsor                    13,000               1          13,000             100       1,300,000
 recordkeeping showing the
 receipt, shipment, or other
 disposition of the
 investigational drug and any
 financial interests............
Sec.   312.62(a); Investigator            13,000               1          13,000              40         520,000
 recordkeeping of the
 disposition of drugs...........
Sec.   312.62(b); Investigator            13,000               1          13,000              40         520,000
 recordkeeping of case histories
 of individuals.................
Sec.   312.160(a)(3); Records                547            1.43             782          * 0.50             391
 pertaining to the shipment of
 drugs for investigational use
 in laboratory research animals
 or in vitro tests..............
Sec.   312.160(c); Shipper                   547            1.43             782          * 0.50             391
 records of alternative
 disposition of unused drugs....
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............       2,343,382
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
* 30 minutes.

               Table 3--Estimated Annual Third-Party Disclosure Burden for Human Drugs (CDER) \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
         21 CFR section              Number of      disclosures    Total annual   Average burden    Total hours
                                    respondents   per respondent    disclosures   per disclosure
----------------------------------------------------------------------------------------------------------------
Sec.   312.53(c); Investigator             1,732            7.94          13,752              80       1,100,160
 reports submitted to the
 sponsor, including Form FDA
 1572, curriculum vitae,
 clinical protocol, and
 financial disclosure...........
Sec.   312.55(a); Investigator               995               4           3,980              48         191,040
 brochures submitted by the
 sponsor to each investigator...
Sec.   312.55(b); Sponsor                    995               4           3,980              48         191,040
 reports to investigators on new
 observations, especially
 adverse reactions and safe use.
Sec.   312.64; Investigator               13,000               1          13,000              24         312,000
 reports to the sponsor,
 including progress reports,
 safety reports, final reports,
 and financial disclosure
 reports........................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............       1,794,240
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

                       Table 4--Estimated Annual Reporting Burden for Biologics (CBER) \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
         21 CFR section              Number of     responses per   Total annual   Average burden    Total hours
                                    respondents     respondent       responses     per response
----------------------------------------------------------------------------------------------------------------
Sec.   312.2(e); Requests for                217            1.18             256              24           6,144
 FDA advice on the applicability
 of part 312 to a planned
 clinical investigation.........
Sec.   312.8; Requests to charge              20            1.50              30              48           1,440
 for an investigational drug....
Sec.   312.10;Requests to waive                2               1               2              24              48
 a requirement in part 312......
Sec.   312.23(a) through (f);                335            1.35             452           1,600         723,200
 IND content and format.........
Sec.   312.30(a) through (e);                694            5.84           4,053             284       1,151,052
 Protocol amendments............
Sec.   312.31 (b); Information                77            2.43             187             100          18,700
 amendments.....................
Sec.   312.32(c) and (d); IND                161            8.83           1,422              32          45,504
 Safety reports.................
Sec.   312.33(a) through (f);                745            2.14           1,594             360         573,840
 IND Annual reports.............
Sec.   312.38(b) and (c);                    134            1.69             226              28           6,328
 Notifications of withdrawal of
 an IND.........................
Sec.   312.42; Sponsor requests               67            1.30              87             284          24,708
 that a clinical hold be
 removed, including sponsor
 submission of a complete
 response to the issues
 identified in the clinical hold
 order..........................
Sec.   312.44(c) and (d);                     34            1.15              39              16             624
 Sponsor responses to FDA when
 IND is terminated..............
Sec.   312.45(a) and (b);                     55            1.38              76              12             912
 Sponsor requests for or
 responses to an inactive status
 determination of an IND by FDA.
Sec.   312.47; Meetings,                      88            1.75             154             160          24,640
 including ``End-of-Phase 2''
 meetings and ``Pre-NDA''
 meetings.......................
Sec.   312.53(c); Investigator               453            6.33           2,867              80         229,360
 reports submitted to the
 sponsor, including Form FDA
 1572, curriculum vitae,
 clinical protocol, and
 financial disclosure...........

Sec.   312.54(a); Sponsor                      1               1               1              48              48
 submissions to FDA concerning
 investigations involving an
 exception from informed consent
 under Sec.   50.24.............
Sec.   312.54(b); Sponsor                      1               1               1              48              48
 notifications to FDA and others
 concerning an IRB determination
 that it cannot approve research
 because it does not meet the
 criteria in the exception from
 informed consent in Sec.
 50.24(a).......................
Sec.   312.55(a); Number of                  239            1.91             456              48          21,888
 investigator brochures
 submitted by the sponsor to
 each investigator..............
Sec.   312.55(b); Number of                  243            4.95           1,203              48          57,744
 sponsor reports to
 investigators on new
 observations, especially
 adverse reactions and safe use.
Sec.   312.56(b), (c), and (d);              108            2.21             239              80          19,120
 Sponsor notifications to FDA
 and others resulting from: (1)
 The sponsor's monitoring of all
 clinical investigations and
 determining that an
 investigator is not in
 compliance with the
 investigation agreements; (2)
 the sponsor's review and
 evaluation of the evidence
 relating to the safety and
 effectiveness of the
 investigational drug; and (3)
 the sponsor's determination
 that the investigational drug
 presents an unreasonable and
 significant risk to subjects...
Sec.   312.58(a); Number of                    7               1               7               8              56
 sponsor's submissions of
 clinical investigation records
 to FDA on request during FDA
 inspections....................
Sec.   312.64; Number of                   2,728            3.82          10,421              24         250,104
 investigator reports to the
 sponsor, including progress
 reports, safety reports, final
 reports, and financial
 disclosure reports.............
Sec.   312.70; During the                      5               1               5              40             200
 disqualification process of a
 clinical investigator by FDA,
 the number of investigator
 responses or requests to FDA
 following FDA's notification to
 an investigator of its failure
 to comply with investigation
 requirements...................
Sec.   312.110(b)(4) and (b)(5);              18               1              18              75           1,350
 Number of written
 certifications and written
 statements submitted to FDA
 relating to the export of an
 investigational drug...........
Sec.   312.120(b); Number of                 280            9.82           2,750              32          88,000
 submissions to FDA of
 ``supporting information''
 related to the use of foreign
 clinical studies not conducted
 under an IND...................
Sec.   312.120(c); Number of                   7            2.29              16              24             384
 waiver requests submitted to
 FDA related to the use of
 foreign clinical studies not
 conducted under an IND.........
Sec.   312.130; Number of                    350            1.34             469               8           3,752
 requests for disclosable
 information in an IND and for
 investigations involving an
 exception from informed consent
 under Sec.   50.24.............
Sec.   312.310(b) and                         78            1.08              84               8             672
 312.305(b); Number of
 submissions related to expanded
 access and treatment of an
 individual patient.............
Sec.   312.310(d);Number of                   76            2.76             210              16           3,360
 submissions related to
 emergency use of an
 investigational new drug.......
Sec.   312.315(c) and                          9               1               9             120           1,080
 312.305(b); Number of
 submissions related to expanded
 access and treatment of an
 intermediate-size patient
 population.....................
Sec.   312.320(b); Number of                   1               1               1             300             300
 submissions related to a
 treatment IND or treatment
 protocol.......................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............       3,254,606
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

                     Table 5--Estimated Annual Recordkeeping Burden for Biologics (CBER) \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
         21 CFR section              Number of      records per    Total annual         per         Total hours
                                   recordkeepers   recordkeeper       records      recordkeeping
----------------------------------------------------------------------------------------------------------------
Sec.   312.52(a); Sponsor                     75            1.40             105               2             210
 records for the transfer of
 obligations to a contract
 research organization..........
Sec.   312.57; Sponsor                       335            2.70             904             100          90,400
 recordkeeping showing the
 receipt, shipment, or other
 disposition of the
 investigational drug, and any
 financial interests............

Sec.   312.62(a); Investigator               453               1             453              40          18,120
 recordkeeping of the
 disposition of drugs...........
Sec.   312.62(b); Investigator               453               1             453              40          18,120
 recordkeeping of case histories
 of individuals.................
Sec.   312.160(a)(3); Records                111            1.40             155           * 0.5              78
 pertaining to the shipment of
 drugs for investigational use
 in laboratory research animals
 or in vitro tests..............
Sec.   312.160(c); Shipper                   111            1.40             155           * 0.5              78
 records of alternative
 disposition of unused drugs....
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............         127,006
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
* 30 minutes.

    Because we have received an increased number of IND submissions
since the last OMB approval of the information collection, we have
increased our estimate of the associated burden accordingly.

    Dated: February 6, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019-01962 Filed 2-11-19; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 87, Number 187 (Wednesday, September 28, 2022)]
[Notices]
[Pages 58896-58897]
[FR Doc No: 2022-20969]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA-2022-1273]

Agency Information Collection Activities: Requests for Comments;
Approval of Clearance Renewal for Information Collection: For the
Information Collection Entitled, Website for Frequency Coordination
Request

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation (DOT).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about our intention to request the Office of
Management and Budget (OMB) approval in accordance with the Paperwork
Reduction Act of 1995, FAA invites public comments about our intention
to request the Office of Management and Budget (OMB) approval to allow
renewal of the currently approved information collection via the FAA's
deployed Web-based Frequency Coordination system (WebFCR), which
collects certain broadcast and transmitter frequency information under
OMB control number 2120-0786. The information collected is needed to
perform the aeronautical studies, technical evaluations required and to
meet the specified requirements for the radio frequency engineering
pursuant to the FAA Order. The Federal Aviation Administration (FAA)
Order 6050.32.B, Chapter 3, Section 302 outlines the US National
Organizations, and the role of the National Telecommunications and
Information Administration (NTIA) is assigning the Aviation Assignment
Group (AAG) of the radio spectrum to FAA which support aeronautical
services. Hence, FAA must ``authorize'' aeronautical frequencies of
broadcast applications which impact the AAG bands.

DATES: Written comments should be submitted by November 28, 2022.

ADDRESSES: Please send written comments:
    By Electronic Docket: https://www.regulations.gov (Enter docket
number into search field).
    By Mail: Christopher S. Jones, Spectrum Engineering and Assignment,
AJW-151, Room 7E-325, 800 Independence Avenue, Washington, DC 20591.
    By Fax:<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Christopher S. Jones by email or phone
at: [email protected]; phone:<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) Whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.
    OMB Control Number: 2120-0786.
    Title: website for Frequency Coordination Request (WebFCR)
webfcr.faa.gov.
    Form Numbers: Historically related to FAA Form 7460-1.
    Type of Review: Request for renewal of information collection.
    Background: 49 U.S.C. Section44718(c) under Broadcast Applications
and Tower Studies states, `In carrying out laws related to a broadcast
application--the Administrator of the Federal Aviation Administration
and the Federal Communications Commission shall take action necessary
to coordinate efficiently--(1) The receipt and consideration of, and
action on, the application; and (2) The completion of any associated
aeronautical study. Currently, transmitter broadcast radio frequency
data is collected via OMB Control 2120-0786 to address non-Federal,
military, U.S. federal agency, state and municipalities broadcast
applications which require consideration, analysis or aeronautical
studies pursuant to 49 U.S.C. Section 44718(c).
    Respondents: Approximately 2400 annually. The Respondents are
engineers, analysts, consultants, stakeholders or federal agency
managers, including military services, who have a need to transmit on a
radio frequency which is within the National Telecommunications and
Information Administration's (NTIA) Aviation Assignment Group (AAG)
frequency band assigned to the FAA for civil aviation use. The response
to this data collection is required for the proponent to obtain FAA
concurrence to use a radio frequency that impacts civil aviation. The
information collected through the WebFCR portal supports the
engineering, modeling, validation and workflow management of the
request to evaluate if the request interferes or

impacts civil aviation operations pursuant to FAA Order 6050.32B.
    Frequency: Information is collected on occasion.
    Estimated Average Burden per Response: 0.2 Hours.
    Estimated Total Annual Burden: 480 Hours.

    Issued in Washington, DC, on September 23, 2022.
Christopher S. Jones,
Spectrum Engineering and Assignment Navigation Lead, Spectrum
Engineering and Assignment Group, AJW-1510.
[FR Doc. 2022-20969 Filed 9-27-22; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 80, Number 190 (Thursday, October 1, 2015)]
[Rules and Regulations]
[Pages 59049-59052]
[FR Doc No: 2015-24827]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 165

[Docket Number USCG-2015-0886]
RIN 1625-AA00

Safety Zone; West Larose Vertical Lift Bridge; Houma, LA

AGENCY: Coast Guard, DHS.

ACTION: Temporary final rule.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard is establishing a temporary safety zone
extending 400 yards east and west of the West Larose Vertical Lift
Bridge in Bayou Lafourche, LA. This safety zone is necessary to protect
persons, property, and infrastructure from potential damage and safety
hazards associated with construction work on the bridge. During the
periods of enforcement, entry into and transiting or anchoring within
this safety zone is prohibited unless specifically authorized by
Captain of the Port (COTP) Morgan City or other designated
representative.

DATES: This rule is effective without actual notice from October 1,
2015 through 3 p.m. on October 2, 2015. For the purposes of
enforcement, actual notice will be used from 6 a.m. to 8 a.m.

and from 1 p.m. to 3 p.m. on September 28, 2015, until October 1, 2015.

ADDRESSES: Documents mentioned in this preamble are part of docket
[USCG-2015-0886]. To view documents mentioned in this preamble as being
available in the docket, go to http://www.regulations.gov, type the
docket number in the ``SEARCH'' box and click ``SEARCH.'' Click on Open
Docket Folder on the line associated with this rulemaking. You may also
visit the Docket Management Facility in Room W12-140 on the ground
floor of the Department of Transportation West Building, 1200 New
Jersey Avenue SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: If you have questions on this rule,
call or email Lieutenant Junior Grade Vanessa Taylor, Chief of
Waterways Management, U.S. Coast Guard MSU Morgan City 800 David Dr,
Morgan City LA,70380; telephone<PHONE_NUMBER>, email
<EMAIL_ADDRESS>If you have questions on viewing or
submitting material to the docket, call Cheryl Collins, Program
Manager, Docket Operations, telephone 1-800-647-5527.

SUPPLEMENTARY INFORMATION:

Table of Acronyms

DHS Department of Homeland Security
FR Federal Register
NPRM Notice of Proposed Rulemaking
MSU Marine Safety Unit

A. Regulatory History and Information

    The Coast Guard is issuing this final rule without prior notice and
opportunity to comment pursuant to authority under section 4(a) of the
Administrative Procedure Act (APA) (5 U.S.C. 553(b)). This provision
authorizes an agency to issue a rule without prior notice and
opportunity to comment when the agency for good cause finds that those
procedures are ``impracticable, unnecessary, or contrary to the public
interest.'' Under 5 U.S.C. 553(b)(B), the Coast Guard finds that good
cause exists for not publishing a notice of proposed rulemaking (NPRM)
with respect to this rule because doing so would be impracticable,
unnecessary, and contrary to the public interest. An NPRM is
impracticable and contrary to the public interest because the Coast
Guard was only notified of the construction on September 08, 2015 and
the work is scheduled to occur from September 28, 2015 through October
2, 2015. Providing a full NPRM process would delay the effectiveness
the temporary safety zone until after the bridge construction project
has been completed and immediate action is needed to protect vessels
and the public from the safety hazards associated with bridge
construction over a public waterway. Furthermore, an NPRM is
unnecessary because the Coast Guard will inform the public through
Broadcast Notice to Mariners, Local Notice to Mariners, and/or Safety
Marine Information Broadcasts of the enforcement period for the safety
zone as well as any changes in the planned and published dates and
times of enforcement.
    For the same reasons, under 5 U.S.C. 553(d)(3), the Coast Guard
finds that good cause exists for making this rule effective less than
30 days after publication in the Federal Register. Delaying the
effectiveness of the rule is impracticable and contrary to the public
interest because the Coast Guard was only notified of the construction
on September 08, 2015 and the work is scheduled to occur from September
28, 2015 through October 02, 2015. Waiting to apply the rule until it
has been published for 30 days would delay the effectiveness the
temporary safety zone until after the bridge construction project has
been completed and immediate action is needed to protect vessels and
the public from the safety hazards associated with bridge construction
over a public waterway. Additionally, the Coast Guard will inform the
public through Broadcast Notice to Mariners, Local Notice to Mariners,
and/or Safety Marine Information Broadcasts of the enforcement period
for the safety zone as well as any changes in the planned and published
dates and times of enforcement.

B. Basis and Purpose

    The legal basis and authorities for this rule are found in 33
U.S.C. 1231; 50 U.S.C. 191; 33 CFR 1.05-1, 6.04-1, 6.04-6, and 160.5;
Department of Homeland Security Delegation no. 0170.1, which
collectively authorize the Coast Guard to establish and define safety
zones.
    The purpose of the rule is to establish the necessary temporary
safety zone to provide protection for persons and property, including
commercial and recreational vessels that may be in the area during the
bridge construction project from the hazards associated with the
project.

C. Discussion of the Final Rule

    The Coast Guard is establishing a temporary safety zone for all
waters in Bayou Lafourche extending 400 yards to the east and west of
the West Larose Vertical Lift Bridge located at position
29[deg]34'142'' N, 090[deg]23'109'' W in Bayou Lafourche, LA from 6
a.m. to 8 a.m. and 1 p.m. to 3 p.m. on September 28, 2015 through
October 2, 2015. This temporary safety zone will be enforced with
actual notice from 6 a.m. to 8 a.m. and 1 p.m. to 3 p.m. on September
28, 2015 through October 2, 2015.
    Entry into, transiting or anchoring within the safety zone is
prohibited unless authorized by the Captain of the Port or his
designated on-scene representative. The Captain of the Port or his
designated on-scene representative may be contacted via VHF Channel 16.

D. Regulatory Analyses

    We developed this rule after considering numerous statutes and
executive orders related to rulemaking. Below we summarize our analyses
based on 13 of these statutes or executive orders.

1. Regulatory Planning and Review

    This rule is not a significant regulatory action under section 3(f)
of Executive Order 12866, Regulatory Planning and Review, as
supplemented by Executive Order 13563, Improving Regulation and
Regulatory Review, and does not require an assessment of potential
costs and benefits under section 6(a)(3) of Executive Order 12866 or
under section 1 of Executive Order 13563. The Office of Management and
Budget has not reviewed it under those Orders.
    We conclude that this rule is not a significant regulatory action
because we anticipate that it will have minimal impact on the economy,
will not interfere with other agencies, will not adversely alter the
budget of any grant or loan recipients, and will not raise any novel
legal or policy issues. The safety zone created by this rule will be
relatively small and enforced over two days. Under certain conditions,
moreover, vessels may still transit through the safety zone when
permitted by the Captain of the Port.

2. Impact on Small Entities

    The Regulatory Flexibility Act of 1980 (RFA), 5 U.S.C. 601-612, as
amended, requires federal agencies to consider the potential impact of
regulations on small entities during rulemaking. The Coast Guard
certifies under 5 U.S.C. 605(b) that this rule will not have a
significant economic impact on a substantial number of small entities.
Under the Regulatory Flexibility Act (5 U.S.C. 601-612), we have
considered the impact of this temporary rule on small entities. This
rule would affect the following entities, some of which might

be small entities: The owners or operators of recreational vessels
intending to transit or anchor in a portion of Bayou Lafourche, LA from
6 a.m. to 8 a.m. and 1 p.m. to 3 p.m. on September 28, 2015 through
October 2, 2015.

3. Collection of Information

    This rule will not call for a new collection of information under
the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520).

4. Federalism

    A rule has implications for federalism under Executive Order 13132,
Federalism, if it has a substantial direct effect on the States, on the
relationship between the national government and the States, or on the
distribution of power and responsibilities among the various levels of
government. We have analyzed this rule under that Order and determined
that this rule does not have implications for federalism.

5. Protest Activities

    The Coast Guard respects the First Amendment rights of protesters.
Protesters are asked to contact the person listed in the FOR FURTHER
INFORMATION CONTACT section to coordinate protest activities so that
your message can be received without jeopardizing the safety or
security of people, places or vessels.

6. Unfunded Mandates Reform Act

    The Unfunded Mandates Reform Act of 1995 (2 U.S.C. 1531-1538)
requires Federal agencies to assess the effects of their discretionary
regulatory actions. In particular, the Act addresses actions that may
result in the expenditure by a State, local, or tribal government, in
the aggregate, or by the private sector of $100,000,000 (adjusted for
inflation) or more in any one year. Though this rule will not result in
such expenditure, we do discuss the effects of this rule elsewhere in
this preamble.

7. Taking of Private Property

    This rule will not cause a taking of private property or otherwise
have taking implications under Executive Order 12630, Governmental
Actions and Interference with Constitutionally Protected Property
Rights.

8. Civil Justice Reform

    This rule meets applicable standards in sections 3(a) and 3(b)(2)
of Executive Order 12988, Civil Justice Reform, to minimize litigation,
eliminate ambiguity, and reduce burden.

9. Protection of Children

    We have analyzed this rule under Executive Order 13045, Protection
or Children from Environmental Health Risks and Safety Risks. This rule
is not an economically significant rule and does not create an
environmental risk to health or risk to safety that may
disproportionately affect children.

10. Indian Tribal Governments

    This rule does not have tribal implications under Executive Order
13175, Consultation and Coordination with Indian Tribal Governments,
because it does not have substantial direct effect on one or more
Indian tribes, on the relationship between the Federal Government and
Indian tribes, or on the distribution or power and responsibilities
between the Federal Government and Indian tribes.

11. Energy Effects

    This action is not a ``significant energy action'' under Executive
Order 13211, Actions Concerning Regulations That Significantly Affect
Energy Supply, Distribution or Use.

12. Technical Standards

    This rule does not use technical standards. Therefore, we did not
consider the use of voluntary consensus standards.

13. Environment

    We have analyzed this rule under Department of Homeland Security
Management Directive 023-01 and Commandant Instruction M16475.1D, which
guide the Coast Guard in complying with the National Environmental
Policy Act of 1969 (NEPA) (42 U.S.C. 4321-4370f), and have determined
that this action is one of a category of actions that do not
individually or cumulatively have a significant effect on the human
environment. This rule involves establishing a safety zone. This rule
is categorically excluded from further review under paragraph 34(g) of
Figure 2-1 of the Commandant Instruction. An environmental analysis
checklist supporting this determination and a Categorical Exclusions
Determination are available in the docket where indicated under
ADDRESSES. We seek any comments or information that may lead to the
discovery of a significant environmental impact from this rule.

List of Subjects in 33 CFR Part 165

    Harbors, Marine Safety, Navigation (waters), Reporting and
recordkeeping requirements, Security measures, Waterways.

    For the reasons discussed in the preamble, the Coast Guard amends
33 CFR part 165 as follows:

PART 165--REGULATED NAVIGATION AREAS AND LIMITED ACCESS AREAS

0
1. The authority citation for Part 165 continues to read as follows:

    Authority:  33 U.S.C. 1231; 50 U.S.C. 191; 33 CFR 1.05-1, 6.04-
1, 6.04-6, and 160.5; Department of Homeland Security Delegation No.
0170.1.

0
2. A new temporary Sec.  165.T08-0886 is added to read as follows:

Sec.  165.T08-0886  Safety Zone; West Larose Vertical Lift Bridge;
Houma, LA.

    (a) Location. All waters of Bayou Lafourche within 400yds to the
east and west of the West Larose Vertical Lift bridge in position
29[deg]34'142'' N., 090[deg]23'109'' W.
    (b) Effective and Enforcement Period. This rule is effective from 6
a.m. to 8 a.m. and from 1 p.m. to 3 p.m. on September 28, 2015 through
October 2, 2015. This rule will be enforced with actual notice from 6
a.m. to 8 a.m. and from 1 p.m. to 3 p.m. on September 28, 2015 through
October 2, 2015.
    (c) Regulations. (1) In accordance with the general regulations in
Sec.  165.23 of this part, entry into, transiting, or anchoring within
this safety zone is prohibited unless authorized by the Captain of the
Port Morgan City, or his designated on-scene representative.
    (2) The ``on-scene representative'' of the Captain of the Port is
any Coast Guard commissioned, warrant, or petty officer who has been
designated by the Captain of the Port to act on his behalf. The on-
scene representative of the Captain of the Port will be aboard either a
Coast Guard or Coast Guard Auxiliary vessel. The Captain of the Port or
his designated on-scene representative may be contacted via VHF Channel
16.
    (3) Vessel operators desiring to enter or operate within the safety
zone shall contact the Captain of the Port Morgan City or his on-scene
representative to obtain permission to do so. Vessel operators given
permission to enter or operate in the safety zone must comply with all
directions given to them by the Captain of the Port Morgan City or his
on-scene representative.
    (d) Informational Broadcasts. The COTP Morgan City or a designated
representative will inform the public through Broadcast Notice to
Mariners, Local Notice to Mariners, and/or Safety Marine Information
Broadcasts of the enforcement period for the safety zone as well as any
changes in the planned and published dates and times of enforcement.

    Dated: September 10, 2015.
F.L. Gilmore,
Captain, U.S. Coast Guard, Acting Captain of the Port Morgan City, LA.
[FR Doc. 2015-24827 Filed 9-30-15; 8:45 am]
 BILLING CODE 9110-04-P


[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Notices]
[Page 14175]
[FR Doc No: 2016-05828]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Agency Information Collection Activities: Requests for Comments;
Clearance of Renewed Approval of Information Collection: Airport Grants
Program

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about our intention to request the Office of
Management and Budget (OMB) approval to revise an information
collection. The FAA collects data from airport sponsors and planning
agencies to determine eligibility, and to ensure proper use of Federal
Funds and project accomplishment for the Airports Grants Program.

DATES: Written comments should be submitted by April 15, 2016.

ADDRESSES: Interested persons are invited to submit written comments on
the proposed information collection to the Office of Information and
Regulatory Affairs, Office of Management and Budget. Comments should be
addressed to the attention of the Desk Officer, Department of
Transportation/FAA, and sent via electronic mail to
<EMAIL_ADDRESS>or faxed to<PHONE_NUMBER>, or mailed to
the Office of Information and Regulatory Affairs, Office of Management
and Budget, Docket Library, Room 10102, 725 17th Street NW.,
Washington, DC 20503.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) Whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.

FOR FURTHER INFORMATION CONTACT: Ronda Thompson at<PHONE_NUMBER>, or
by email at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    OMB Control Number: 2120-0569.
    Title: Airport Grants Program.
    Form Numbers: FAA Forms 5100-100, 5100-101, 5100-108, 5100-125,
5100-126, 5370-1, 5100-110, 5100-128, 5100-129, 5100-130, 5100-131,
5100-132, 5100-133, 5100-134, 5100-135, 5100-136, 5100-137, 5100-138,
5100-139, 5100-140, 5100-141, 5100-142.
    Type of Review: Revision of an information collection.
    Background: The Federal Register Notice with a 60-day comment
period soliciting comments on the following collection of information
was published on December 16, 2015 (80 FR 78284). No comments were
received. Codification of Certain U.S. Transportation Laws at 49
U.S.C., repealed the Airport and Airway Improvement Act of 1982, as
amended, and the Aviation Safety and Noise Abatement Act of 1979, as
amended, and re-codified them without substantive change at Title 49,
U.S.C., which is referred to as the ``Act''. The Act provides funding
for airport planning and development projects at airports included in
the National Plan of Integrated Airport Systems. The Act also
authorizes funds for noise compatibility planning and to carry out
noise compatibility programs. The information required by this program
is necessary to protect the Federal interest in safety, efficiency, and
utility of the Airport. Data is collected to meet report requirements
of 2 CFR part 200 for certifications and representations, financial
management and performance measurement.
    Respondents: Approximately 12,607 applicants.
    Frequency: Information is collected on occasion.
    Estimated Average Burden per Response: 9 hours.
    Estimated Total Annual Burden: 117,699 hours.

    Issued in Washington, DC, on March 9, 2016.
Ronda Thompson,
FAA Information Collection Clearance Officer, Performance, Policy &
Records Management Branch, ASP-110.
[FR Doc. 2016-05828 Filed 3-15-16; 8:45 am]
 BILLING CODE 4910-13-P


[Federal Register Volume 85, Number 43 (Wednesday, March 4, 2020)]
[Notices]
[Pages 12779-12780]
[FR Doc No: 2020-04396]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

    Docket Numbers: CP18-102-001.
    Applicants: Cheyenne Connector, LLC.
    Description: Amendment to Certificate of Public Convenience and
Necessity of Cheyenne Connector, LLC.
    Filed Date: 2/25/20.
    Accession Number: 20200225-5032.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: CP18-103-001.
    Applicants: Rockies Express Pipeline LLC.
    Description: Amendment to Certificate of Public Convenience and
Necessity of Rockies Express Pipeline LLC.
    Filed Date: 2/24/20.
    Accession Number: 20200224-5151.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-546-000.
    Applicants: Vector Pipeline L. P.
    Description: Annual Fuel Use Report for 2019 of Vector Pipeline L.
P. under RP20-546.
    Filed Date: 2/25/20.
    Accession Number: 20200225-5088.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-547-000.
    Applicants: Algonquin Gas Transmission, LLC.

    Description: Sec.  4(d) Rate Filing: NRA Name Change Cleanup GenOn
to Canal to be effective 3/27/2020.
    Filed Date: 2/25/20.
    Accession Number: 20200225-5101.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-548-000.
    Applicants: Viking Gas Transmission Company.
    Description: Sec.  4(d) Rate Filing: Annual LMCRA--Spring 2020 to
be effective 4/1/2020.
    Filed Date: 2/25/20.
    Accession Number: 20200225-5147.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-516-001.
    Applicants: Gulf South Pipeline Company, LLC.
    Description: Tariff Amendment: Amendment to Docket No. RP20-516-000
to be effective 4/1/2020.
    Filed Date: 2/26/20.
    Accession Number: 20200226-5029.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-549-000.
    Applicants: Rover Pipeline LLC.
    Description: Sec.  4(d) Rate Filing: Housekeeping on 2-26-20 to be
effective 3/27/2020.
    Filed Date: 2/26/20.
    Accession Number: 20200226-5025.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-550-000.
    Applicants: Midcontinent Express Pipeline LLC.
    Description: Compliance filing Annual Report of Operational
Purchases and Sales 2020.
    Filed Date: 2/26/20.
    Accession Number: 20200226-5038.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-551-000.
    Applicants: Guardian Pipeline, L.L.C.
    Description: Sec.  4(d) Rate Filing: EPCR Semi-Annual Adjustment--
Spring 2020 to be effective 4/1/2020.
    Filed Date: 2/26/20.
    Accession Number: 20200226-5045.
    Comments Due: 5 p.m. ET 3/9/20.

    Docket Numbers: RP20-552-000.
    Applicants: Texas Eastern Transmission, LP.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--EcoEnergy
eff 3-1-2020 to be effective 3/1/2020.
    Filed Date: 2/26/20.
    Accession Number: 20200226-5049.
    Comments Due: 5 p.m. ET 3/9/20.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: February 26, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-04396 Filed 3-3-20; 8:45 am]
 BILLING CODE 6717-01-P


than quarterly; (ii) Requiring respondents to prepare a written response
to a collection of information in fewer than 30 days after receipt of
it;

 The facility type indicator field was used in PCS to categorize whether
a facility was municipal or non-municipal.  All facilities coded as
“M” for “Municipal” were selected as Municipal facilities.  All
facilities coded as “I” for “Industrial,” “F” for
“Federal,” or “O” for “Other” were selected as Non-Municipal
facilities.

 See EPA ICR No. 1427.07 for detailed explanation of the assumptions
regarding Part 435

 These numbers are expected to decrease when the 2003 CAFO rule is
revised to incorporate the February 28, 2005 decision of the U.S. Second
Circuit Court of Appeals that reduced the number of CAFOs required to
have NPDES permits.

 In the previous 2004 ICR (EPA ICR No. 1427.07) EPA estimated that 75
percent of the major facilities would submit compliance schedule reports
per year.  The percentage was revised based on input from EPA’s Water
Permits Division, 2007.

 This number is expected to decrease when the 2003 CAFO rule is revised
to incorporate the February 28, 2005 decision of the U.S. Second Circuit
Court of Appeals that reduced the number of CAFOs required to have NPDES
permits.

 Calculations for the number or respondents for other noncompliance were
incorrect in the 2004 ICR. Corrections are taken for this ICR. In 2004
the number of major and minor permits administered by the state was
5,678 and 42,472 respectively. The number of major and minor permits
administered by the EPA was 887 and 2,487 respectively. Following the
logic presented in the text, Exhibit 9 should have reported 538
(5,678*0.02 + 42,472*0.01) permits for states and 43 (887*0.02 +
2,487*0.01) permits for EPA submitting other noncompliance; instead, it
reported 1,926 and 134.

 See EPA ICR No. 1427.07 for detailed
explanation漠桴獡畳灭楴湯⁳敲慧摲湩慐瑲㐠㔳മ
̍഍ഄ̍഍ഄࠍ഍ഈࠍ഍ഈࠍ剄䙁⁔潃灭楬湡散䄠獳獥
浳湥⁴䍉॒慐敧
ࠍഈऍ畊敮㈠〰ഷࠍ഍ഈࠍ剄䙁⁔潃灭楬湡散䄠獳獥浳
湥⁴䍉॒慐敧
ࠍഈऍ畊敮㈠〰ഷࠍ഍ഈࠍ剄䙁⁔潃灭楬湡散䄠獳獥浳
湥⁴䍉॒慐敧
ࠍഈऍ畊敮㈠〰ഷࠍ഍ഈࠍ剄䙁⁔潃灭楬湡散䄠獳獥浳
湥⁴䍉॒慐敧
ࠍഈऍ畊敮㈠〰ഷࠍ഍ഈࠍ剄䙁⁔潃灭楬湡散䄠獳獥浳
湥⁴䍉॒慐敧
ࠍഈऍ畊敮㈠〰ഷࠍ഍഍഍഍഍഍഍഍഍


[Federal Register Volume 87, Number 75 (Tuesday, April 19, 2022)]
[Rules and Regulations]
[Pages 23110-23111]
[FR Doc No: 2022-08289]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

49 CFR Part 586

[Docket No. NHTSA-2021-0006]
RIN 2127-AL77

Vehicle Identification Number (VIN) Requirements; Manufacturer
Identification; Certification; Replica Motor Vehicles; Importation of
Vehicles and Equipment Subject to Federal Safety, Bumper, and Theft
Prevention Standards

AGENCY: National Highway Traffic Safety Administration (NHTSA),
Department of Transportation (DOT).

ACTION: Correcting amendment.

-----------------------------------------------------------------------

SUMMARY: On March 9, 2022, the NHTSA issued regulations implementing
the Replica Motor Vehicle program. That document included an
incorrectly designated paragraph in the final regulatory text for the
section titled ``Temporary labels.'' This document corrects the final
regulatory text.

DATES: Effective April 19, 2022.

FOR FURTHER INFORMATION CONTACT: For further information you may
contact Ms. Callie Roach, telephone<PHONE_NUMBER>, [email protected];
Mr. Daniel Koblenz, telephone<PHONE_NUMBER>, [email protected];
Office of the Chief Counsel. The mailing address of these officials is:
National Highway Traffic Safety Administration, 1200 New Jersey Avenue
SE, West Building, Washington, DC 20590.

SUPPLEMENTARY INFORMATION: This document makes a correction to final
regulatory text that was published in the Federal Register on March 9,
2022 (87 FR 13209).

List of Subjects in 49 CFR Part 586

    Labeling, Motor vehicle safety, Replica motor vehicles, Reporting
and recordkeeping requirements.

    In consideration of the foregoing, NHTSA corrects 49 CFR part 586
as follows:

PART 586--REPLICA MOTOR VEHICLES

0
1. The authority citation for part 586 continues to read as follows:

    Authority: 49 U.S.C. 30112 and 30114; delegation of authority at
49 CFR 1.95.

Sec.  586.11   [Amended]

0
2. In Sec.  586.11, redesignate paragraph (b)(3) as paragraph (c).

    Issued under authority delegated in 49 CFR part 1.95 and 49 CFR
501.8.
Raymond R. Posten,
Associate Administrator for Rulemaking.
[FR Doc. 2022-08289 Filed 4-18-22; 8:45 am]
BILLING CODE 4910-59-P


[Federal Register Volume 82, Number 122 (Tuesday, June 27, 2017)]
[Notices]
[Pages 29064-29065]
[FR Doc No: 2017-13384]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER17-1871-000]

Bayshore Solar B, LLC; Supplemental Notice That Initial Market-
Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding of
Bayshore Solar B, LLC's application for market-based rate authority,
with an accompanying rate tariff, noting that such application includes
a request for

blanket authorization, under 18 CFR part 34, of future issuances of
securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is July 11, 2017.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
eSubscription link on the Web site that enables subscribers to receive
email notification when a document is added to a subscribed docket(s).
For assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.

    Dated: June 21, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2017-13384 Filed 6-26-17; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: March 15, 2010 (Volume 75, Number 49)]
[Notices]
[Page 12232-12233]
[DOCID:fr15mr10-51]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-ORD-2010-0202; FRL-9127-4]

Board of Scientific Counselors, Executive Committee Meeting--
April 2010

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92-
463, the Environmental Protection Agency, Office of Research and
Development (ORD), gives notice of a public meeting (via conference
call) of the Board of Scientific Counselors (BOSC) Executive Committee.

DATES: The conference call will be held on Thursday, April 1, 2010,
from 11 a.m. to 1 p.m. eastern time, and may adjourn early if all
business is finished. Requests for the draft agenda or for making oral
presentations at the meeting will be accepted up to one business day
before the meeting.

ADDRESSES: Participation in the conference call will be by
teleconference only--meeting rooms will not be used. Members of the
public may obtain the call-in number and access code for the calls from
Greg Susanke, whose contact information is listed under the FOR FURTHER
INFORMATION CONTACT section of this notice.
    Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2010-
0202, by one of the following methods:
     http://www.regulations.gov: Follow the on-line
instructions for submitting comments.
     E-mail: Send comments by electronic mail (e-mail) to:
<EMAIL_ADDRESS>Attention Docket ID No. EPA-HQ-ORD-2010-0202.
     Fax: Fax comments to:<PHONE_NUMBER>, Attention Docket ID
No. EPA-HQ-ORD-2010-0202.
     Mail: Send comments by mail to: Board of Scientific
Counselors, Executive Committee Meeting--February 2010 Docket,
Mailcode: 2822T, 1301 Constitution Avenue., NW., Washington, DC 20004,
Attention Docket ID No. EPA-HQ-ORD-2010-0202.
     Hand Delivery or Courier. Deliver comments to: EPA Docket
Center (EPA/DC), Room 3334, EPA West Building, 1301 Constitution
Avenue, NW., Washington, DC, Attention Docket ID No. EPA-HQ-ORD-2010-
0202. Deliveries are only accepted during the docket's normal hours of
operation, and special arrangements should be made for deliveries of
boxed information.

    Instructions: Direct your comments to Docket ID No. EPA-HQ-ORD-
2010-0202. EPA's policy is that all comments received will be included
in the public docket without change and may be made available online at
http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://
www.regulations.gov or e-mail. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through http://www.regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses. For additional information about EPA's public
docket visit the EPA Docket Center homepage at http://www.epa.gov/
dockets.
    Docket: All documents in the docket are listed in the http://
www.regulations.gov index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, will be publicly available only in hard copy.
Publicly available docket materials are available either electronically
in http://www.regulations.gov or in hard copy at the Board of
Scientific Counselors, Executive Committee Meeting--February 2010
Docket, EPA/DC, EPA West, Room 3334, 1301 Constitution Ave., NW.,
Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Public Reading Room is<PHONE_NUMBER>, and the telephone
number for the ORD Docket is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: The Designated Federal Officer via
mail at: Greg Susanke, Mail Code 8104-R, Office of Science Policy,
Office of Research and Development, Environmental Protection Agency,
1200 Pennsylvania Avenue, NW., Washington, DC 20460; via phone/voice
mail at:<PHONE_NUMBER>; via fax at:<PHONE_NUMBER>; or via e-mail at:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

General Information

    Any member of the public interested in receiving a draft BOSC
agenda or making a presentation at the meeting may contact Greg
Susanke, the Designated Federal Officer, via any of the contact methods
listed in the FOR FURTHER INFORMATION CONTACT section above. In
general, each individual making an oral presentation will be limited to
a total of three minutes.
    Proposed agenda items for the meeting include, but are not limited
to: ORD response to BOSC Clean Air Report; and finalization of BOSC
Decision Analysis Workshop Report. The meeting is open to the public.
    Information on Services for Individuals with Disabilities: For
information on access or services for individuals with disabilities,
please contact Greg Susanke<PHONE_NUMBER> or<EMAIL_ADDRESS>To
request accommodation of a disability, please contact Greg Susanke,
preferably at least 10 days prior to the meeting, to give EPA as much
time as possible to process your request.

    Dated: March 2, 2010.
Fred S. Hauchman,
Director, Office of Science Policy.
[FR Doc. 2010-5591 Filed 3-12-10; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 87, Number 110 (Wednesday, June 8, 2022)]
[Notices]
[Pages 34871-34872]
[FR Doc No: 2022-12331]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC22-71-000.
    Applicants: Canal Generating LLC, Canal 3 Generating LLC, Bucksport
Generation LLC, Stonepeak Kestrel Energy Marketing LLC.
    Description: Joint Application for Authorization Under Section 203
of the Federal Power Act of Canal Generating LLC, et al.
    Filed Date: 6/1/22.
    Accession Number: 20220601-5359.
    Comment Date: 5 p.m. ET 6/22/22.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER20-2341-003.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Compliance filing: 2022-06-02_SA 3518 Deficiency
Response ITC Midwest-Interstate Sub FSA (J416) to be effective 7/1/
2020.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5067.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER20-2382-003.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Compliance filing: 2022-06-02_SA 3516 Deficiency
Response Ameren-Broadlands 2nd Sub FSA GIA (J468) to be effective 10/1/
2020.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5065.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER20-2385-002.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Compliance filing: 2022-06-02_SA 3025 Deficiency
Response Ameren-Broadland Sub 1st Rev FCA (J468) to be effective 7/9/
2020.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5058.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER20-2386-002.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Compliance filing: 2022-06-02_SA 3024 Deficiency
Response Broadlands-Ameren Sub 2nd Rev GIA (J468) to be effective 7/9/
2020.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5063.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER20-2408-003.
    Applicants: Midcontinent Independent System Operator, Inc.
    Description: Compliance filing: 2022-06-02_SA 3524 Deficiency
Response Ameren-Broadlands 2nd Sub FSA (J468) to be effective 10/1/
2020.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5054.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER21-57-000.
    Applicants: Shell Energy North America (US), L.P.
    Description: Refund Report: Refund Report to be effective N/A.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5145.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2009-000.
    Applicants: Duke Energy Progress, LLC.
    Description: Sec.  205(d) Rate Filing: DEP--Excel--Generation
Replacement Coordinator Agreement RS No. 404 to be effective 8/1/2022.
    Filed Date: 6/1/22.
    Accession Number: 20220601-5267.
    Comment Date: 5 p.m. ET 6/22/22.

    Docket Numbers: ER22-2011-000.
    Applicants: Duke Energy Carolinas, LLC.
    Description: Sec.  205(d) Rate Filing: DEC-Excel Generation
Replacement Coordinator Agreements RS No. 588 to be effective 8/1/2022.
    Filed Date: 6/1/22.
    Accession Number: 20220601-5274.
    Comment Date: 5 p.m. ET 6/22/22.

    Docket Numbers: ER22-2012-000.
    Applicants: AEP Texas Inc.
    Description: Sec.  205(d) Rate Filing: AEPTX-Monte Alto Windpower
5th A&R Generation Interconnection Agreement to be effective 5/6/2022.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5052.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2013-000.
    Applicants: AEP Texas Inc.
    Description: Sec.  205(d) Rate Filing: AEPTX-House Mountain 1st A&R
Generation Interconnection Agreement to be effective 5/9/2022.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5057.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2015-000.
    Applicants: Tampa Electric Company.
    Description: Tampa Electric Company submitted a Motion Requesting
Waiver of The Formula Rate Implementation with Shortened Comment Period
Request under ER22-2015.
    Filed Date: 5/27/22.
    Accession Number: 20220527-5369.
    Comment Date: 5 p.m. ET 6/6/22.

    Docket Numbers: ER22-2016-000.
    Applicants: Louisiana Energy and Power Authority.
    Description: Request to Recover Costs Associated with Acting as a
Local Balancing Authority of Louisiana Energy and Power Authority.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5108.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2017-000.
    Applicants: PacifiCorp.
    Description: Sec.  205(d) Rate Filing: Dugway Non-Conforming
Amended SGIA to be effective 8/2/2022.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5114.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2018-000.
    Applicants: California Independent System Operator Corporation.
    Description: Sec.  205(d) Rate Filing: 2022-06-02 Interconnection
Process Enhancements Tariff Amendment to be effective 9/1/2022.
    Filed Date: 6/2/22.

    Accession Number: 20220602-5133.
    Comment Date: 5 p.m. ET 6/23/22.

    Docket Numbers: ER22-2019-000.
    Applicants: Manchief Power Company LLC.
    Description: Tariff Amendment: Notice of Cancellation to be
effective 6/3/2022.
    Filed Date: 6/2/22.
    Accession Number: 20220602-5141.
    Comment Date: 5 p.m. ET 6/23/22.

    Take notice that the Commission received the following qualifying
facility filings:

    Docket Numbers: QF22-683-000.
    Applicants: Saint-Gobain Abrasives.
    Description: Form 556 of Saint-Gobain Abrasives.
    Filed Date: 6/1/22.
    Accession Number: 20220601-5228.
    Comment Date: 5 p.m. ET 6/22/22.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: June 2, 2022.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2022-12331 Filed 6-7-22; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 76, Number 185 (Friday, September 23, 2011)]
[Proposed Rules]
[Pages 59087-59088]
[FR Doc No: 2011-24518]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R03-OAR-2011-0721; FRL-9470-9]

Approval and Promulgation of Air Quality Implementation Plans;
Delaware; Adhesives and Sealants Rule

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA is proposing to approve State Implementation Plan (SIP)
revision submitted by the State of Delaware. The SIP revision adds
section 4.0, under Regulation 1141, relating to the control of
emissions of volatile organic compounds (VOC) from the manufacture,
sale, use, or application of adhesives, sealants, primers, and
solvents. This action is being taken under the Clean Air Act (CAA).

DATES: Written comments must be received on or before October 24, 2011.

ADDRESSES: Submit your comments, identified by Docket ID Number EPA-
R03-OAR-2011-0721 by one of the following methods:
    A. http://www.regulations.gov. Follow the on-line instructions for
submitting comments.
    B. E-mail<EMAIL_ADDRESS>    C. Mail: EPA-R03-OAR-2011-0721, Cristina Fernandez, Associate
Director, Office of Air Program Planning, Mailcode 3AP30, U.S.
Environmental Protection Agency, Region III, 1650 Arch Street,
Philadelphia, Pennsylvania 19103.
    D. Hand Delivery: At the previously-listed EPA Region III address.
Such deliveries are only accepted during the Docket's normal hours of
operation, and special arrangements should be made for deliveries of
boxed information.
    Instructions: Direct your comments to Docket ID Number EPA-R03-OAR-
2011-0721. EPA's policy is that all comments received will be included
in the public docket without change, and may be made available online
at  http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://www.regulations.gov or e-mail. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through http://www.regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses.
    Docket: All documents in the electronic docket are listed in the
http://www.regulations.gov index. Although listed in the index, some
information is not publicly available, i.e., CBI or other information
whose disclosure is restricted by statute. Certain other material, such
as copyrighted material, is not placed on the Internet and will be
publicly available only in hard copy form. Publicly available docket
materials are available either electronically in http://www.regulations.gov or in hard copy during normal business hours at the
Air Protection Division, U.S. Environmental Protection Agency, Region
III, 1650 Arch Street, Philadelphia, Pennsylvania 19103. Copies of the
State submittal are available at the Delaware Department of Natural
Resources and Environmental Control, 89 Kings Highway, P.O. Box 1401,
Dover, Delaware 19903.

FOR FURTHER INFORMATION CONTACT: Gregory Becoat,<PHONE_NUMBER>, or by
e-mail at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    On June 9, 2009, the Delaware Department of Natural Resources and
Environmental Control (DNREC) submitted a revision to the Delaware SIP.
The SIP revision consists of Delaware's regulation for reducing VOCs
from commercially-used adhesive and sealant products by adding section
4.0--Adhesives and Sealants under Regulation 1141--Limiting Emissions
of Volatile Organic Compounds from Consumer and Commercial Products.
The revisions are part of Delaware's strategy to achieve and maintain
the 8-hour ozone national ambient air quality standard (NAAQS)
throughout the State.

III. Summary of SIP Revision

    The SIP revision consists of the following amendments:

New Regulation--Regulation 1141 Section 4.0--Adhesives and Sealants

    Section 4.0 is a new regulation based on the Ozone Transport
Commission (OTC) model rule that in turn was based on the California
Air Resources Board (CARB) model rule. Section 4.0 addresses adhesive,
sealants, adhesive primers, and sealant primers that are sold in larger
containers and used primarily in commercial and industrial
applications, which include residential applications of these products,
such as carpet, flooring, and roofing installations.
    The OTC states developed a model rule ``OTC Model Rule For
Adhesives and Sealants'' dated 2006 which was based on the 1998 CARB
reasonably available control technology (RACT) determination. This RACT
determination applied to both the manufacture and use of adhesives,
sealants, adhesive primers, or sealant primers, in both industrial and
manufacturing facilities and in the field. California Air Districts
used this determination to develop regulations for this category. EPA
addressed this source category with a Control Techniques Guideline
(CTG) document for Miscellaneous Industrial Adhesives, dated September
2008. This CTG was developed in response to section 183(e) of the CAA
requirement for EPA to study and regulate consumer and commercial
products, which is included in EPA's Report to Congress, ``Study of
Volatile Organic Compound Emissions from Consumer and Commercial
Products--Comprehensive Emissions Inventory.'' The miscellaneous
industrial adhesives category was limited to adhesives and adhesive
primers used in industrial and manufacturing operations and did not
include products applied in the field. Therefore, the OTC model rule
and state efforts in developing individual regulations preceded EPA's
CTG for this source category and were broader in applicability.
    The new section 4.0 adds regulations that: (a) Set standards for
the application of adhesives, sealants, adhesive primers, and sealant
primers by providing options for appliers either to use a product with
a VOC content equal to or less than a specified limit or to use add-on
controls; (b) add definitions and terms for new product categories; (c)
establish that any person may not use or apply at the facility an
adhesive, sealant, adhesive primer or sealant primer that exceeds the
VOC content limits; (d) specify requirements for person of a facility
that uses or applies a surface preparation solvent or cleanup solvent
or removes an adhesive, sealant, adhesive primer, and sealant primer
from the parts of spray application equipment; (e) provide for an
alternative add-on control system requirement of at least 85 percent
overall control efficiency (capture and destruction), by weight; (f)
specify requirements for proper storage and disposal, work practices,
surface preparation, and cleanup solvent composition; and (g) specify
exemptions, as well as registration and product labeling requirements,
recordkeeping requirements, and test methods and compliance procedures.
    A detailed summary of EPA's review of and rationale for proposing
to approve this SIP revision may be found in the Technical Support
Document (TSD) for this action which is available on-line at http://www.regulations.gov, Docket number EPA-R03-OAR-2011-0721.

III. Proposed Action

    EPA is proposing to approve the Delaware SIP revision adding
section 4.0--Adhesives and Sealants to Regulation 1141--Limiting
Emissions of Volatile Organic Compounds from Consumer and Commercial
Products. EPA is soliciting public comments on the issues discussed in
this document. These comments will be considered before taking final
action.

IV. Statutory and Executive Order Reviews

    Under the CAA, the Administrator is required to approve a SIP
submission that complies with the provisions of the CAA and applicable
Federal regulations. 42 U.S.C. 7410(k); 40 CFR 52.02(a). Thus, in
reviewing SIP submissions, EPA's role is to approve state choices,
provided that they meet the criteria of the CAA. Accordingly, this
action merely proposes to approve state law as meeting Federal
requirements and does not impose additional requirements beyond those
imposed by State law. For that reason, this proposed action:
     Is not a ``significant regulatory action'' subject to
review by the Office of Management and Budget under Executive Order
12866 (58 FR 51735, October 4, 1993);
     Does not impose an information collection burden under the
provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.);
     Is certified as not having a significant economic impact
on a substantial number of small entities under the Regulatory
Flexibility Act (5 U.S.C. 601 et seq.);
     Does not contain any unfunded mandate or significantly or
uniquely affect small governments, as described in the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4);
     Does not have Federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999);
     Is not an economically significant regulatory action based
on health or safety risks subject to Executive Order 13045 (62 FR
19885, April 23, 1997);
     Is not a significant regulatory action subject to
Executive Order 13211 (66 FR 28355, May 22, 2001);
     Is not subject to requirements of Section 12(d) of the
National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272
note) because application of those requirements would be inconsistent
with the CAA; and
     Does not provide EPA with the discretionary authority to
address, as appropriate, disproportionate human health or environmental
effects, using practicable and legally permissible methods, under
Executive Order 12898 (59 FR 7629, February 16, 1994).

In addition, this proposed rule, pertaining to Delaware's control of
VOCs from adhesives and sealants, does not have Tribal implications as
specified by Executive Order 13175 (65 FR 67249, November 9, 2000),
because the SIP is not approved to apply in Indian country located in
the state, and EPA notes that it will not impose substantial direct
costs on Tribal governments or preempt Tribal law.

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Ozone, Reporting
and recordkeeping requirements, Volatile organic compounds.

    Authority: 42 U.S.C. 7401 et seq.

    Dated: September 6, 2011.
James W. Newsom,
Acting, Regional Administrator, Region III.
[FR Doc. 2011-24518 Filed 9-22-11; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 76, Number 232 (Friday, December 2, 2011)]
[Notices]
[Pages 75545-75547]
[FR Doc No: 2011-31028]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9497-3]

Proposed Consent Decree, Clean Air Act Citizen Suit

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of proposed consent decree; request for public comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 113(g) of the Clean Air Act, as
amended (``CAA'' or the ``Act''), 42 U.S.C. 7413(g), notice is hereby
given of a proposed consent decree to address a lawsuit filed by El
Comit[eacute] para el Bienestar de Earlimart and Association of
Irritated Residents (collectively ``Plaintiffs'') in the United States
District Court for the Northern District of California: El
Comit[eacute] para el Bienestar de Earlimart, et al. v. Jackson, No.
11-cv-3779 (N.D. Cal). On August 1, 2011, Plaintiffs filed a complaint
alleging that EPA failed to perform a mandatory duty under section
110(k)(2) of the CAA, 42

U.S.C. 7410(k)(2) to take timely final action to approve, disapprove,
or partially approve/disapprove the proposed state implementation plan
commitment for the San Joaquin Valley, as well as regulations
pertaining to field fumigation methods, pesticide emission inventory,
and field fumigation limits. The proposed consent decree establishes a
deadline for EPA to take action.

DATES: Written comments on the proposed consent decree must be received
by January 3, 2012.

ADDRESSES: Submit your comments, identified by Docket ID number EPA-HQ-
OGC-2011-0930, online at http://www.regulations.gov (EPA's preferred
method); by email to<EMAIL_ADDRESS>by mail to EPA Docket Center,
Environmental Protection Agency, Mailcode: 2822T, 1200 Pennsylvania
Ave. NW., Washington, DC 20460-0001; or by hand delivery or courier to
EPA Docket Center, EPA West, Room 3334, 1301 Constitution Ave. NW.,
Washington, DC, between 8:30 a.m. and 4:30 p.m. Monday through Friday,
excluding legal holidays. Comments on a disk or CD-ROM should be
formatted in Word or ASCII file, avoiding the use of special characters
and any form of encryption, and may be mailed to the mailing address
above.

FOR FURTHER INFORMATION CONTACT: Jan Tierney, Air and Radiation Law
Office (2344A), Office of General Counsel, U.S. Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460;
telephone:<PHONE_NUMBER>; fax number<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Additional Information About the Proposed Consent Decree

    The proposed consent decree would resolve a lawsuit seeking to
compel the Administrator to take timely final action under section
110(k) of the CAA to approve, disapprove, or partially approve/
disapprove the proposed state implementation plan commitment for the
San Joaquin Valley (Pesticide Element SIP Submittal), as well as
regulations pertaining to field fumigation methods, pesticide emission
inventory, and field fumigation limits (Fumigant Rules SIP Submittal),
which were submitted to EPA on October 12, 2009. The proposed consent
decree requires that no later than April 15, 2012, EPA shall sign a
notice or notices of the Agency's proposed action or actions on the
Revised Pesticide Element SIP Submittal and the Fumigant Rules SIP
Submittal pursuant to Section 110(k) of the CAA, 42 U.S.C. 7410(k). The
proposed consent decree further provides that no later than August 15,
2012, EPA shall sign a notice or notices of the Agency's final action
or actions on the Revised Pesticide Element SIP Submittal and the
Fumigant Rules SIP Submittal pursuant to Section 110(k) of the CAA, 42
U.S.C. 7410(k). No later than 15 business days following signature, EPA
shall send the notice or notices to the Office of the Federal Register
for review and publication in the Federal Register. After EPA fulfills
its obligations under the decree, the parties shall file a joint
request to the Court to dismiss this matter with prejudice.
    For a period of thirty (30) days following the date of publication
of this notice, the Agency will accept written comments relating to the
proposed consent decree from persons who were not named as parties or
intervenors to the litigation in question. EPA or the Department of
Justice may withdraw or withhold consent to the proposed consent decree
if the comments disclose facts or considerations that indicate that
such consent is inappropriate, improper, inadequate, or inconsistent
with the requirements of the Act. Unless EPA or the Department of
Justice determines that consent to this consent decree should be
withdrawn, the terms of the decree will be affirmed.

II. Additional Information About Commenting on the Proposed Consent
Decree

A. How can I get a copy of the consent decree?

    The official public docket for this action (identified by Docket ID
No. EPA-HQ-OGC-2011-0930) contains a copy of the proposed consent
decree. The official public docket is available for public viewing at
the Office of Environmental Information (OEI) Docket in the EPA Docket
Center, EPA West, Room 3334, 1301 Constitution Ave. NW., Washington,
DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to
4:30 p.m., Monday through Friday, excluding legal holidays. The
telephone number for the Public Reading Room is<PHONE_NUMBER>, and the
telephone number for the OEI Docket is<PHONE_NUMBER>.
    An electronic version of the public docket is available through
http://www.regulations.gov. You may use http://www.regulations.gov to
submit or view public comments, access the index listing of the
contents of the official public docket, and to access those documents
in the public docket that are available electronically. Once in the
system, key in the appropriate docket identification number then select
``search''.
    It is important to note that EPA's policy is that public comments,
whether submitted electronically or in paper, will be made available
for public viewing online at http://www.regulations.gov without change,
unless the comment contains copyrighted material, CBI, or other
information whose disclosure is restricted by statute. Information
claimed as CBI and other information whose disclosure is restricted by
statute is not included in the official public docket or in the
electronic public docket. EPA's policy is that copyrighted material,
including copyrighted material contained in a public comment, will not
be placed in EPA's electronic public docket but will be available only
in printed, paper form in the official public docket. Although not all
docket materials may be available electronically, you may still access
any of the publicly available docket materials through the EPA Docket
Center.

B. How and to whom do I submit comments?

    You may submit comments as provided in the ADDRESSES section.
Please ensure that your comments are submitted within the specified
comment period. Comments received after the close of the comment period
will be marked ``late.'' EPA is not required to consider these late
comments.
    If you submit an electronic comment, EPA recommends that you
include your name, mailing address, and an email address or other
contact information in the body of your comment and with any disk or CD
ROM you submit. This ensures that you can be identified as the
submitter of the comment and allows EPA to contact you in case EPA
cannot read your comment due to technical difficulties or needs further
information on the substance of your comment. Any identifying or
contact information provided in the body of a comment will be included
as part of the comment that is placed in the official public docket,
and made available in EPA's electronic public docket. If EPA cannot
read your comment due to technical difficulties and cannot contact you
for clarification, EPA may not be able to consider your comment.
    Use of the http://www.regulations.gov Web site to submit comments
to EPA electronically is EPA's preferred method for receiving comments.
The electronic public docket system is an ``anonymous access'' system,
which means EPA will not know your identity, email address, or other
contact information unless you provide it in the body of your comment.

In contrast to EPA's electronic public docket, EPA's electronic mail
(email) system is not an ``anonymous access'' system. If you send an
email comment directly to the Docket without going through http://www.regulations.gov, your email address is automatically captured and
included as part of the comment that is placed in the official public
docket, and made available in EPA's electronic public docket.

Kevin McLean,
Acting Associate General Counsel.
[FR Doc. 2011-31028 Filed 12-1-11; 8:45 am]
BILLING CODE 6560-50-P